Trial Profile
Clinical study of Combined action of Icotinib and brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs Icotinib (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 25 Jul 2017 New trial record